Evidence map›Paper›PMID 42206241›Full record

ArticleJournal of pediatrics. Clinical practice2026

Nebulized-Swallowed Albuterol for the Treatment of Food Impaction in Pediatric Patients with Eosinophilic Esophagitis: A Novel Nonendoscopic Approach.

Thirumazhisai S Gunasekaran, Kiranmai Gorla, James Berman, Vrinda Bhardwaj

Abstract read
In one paragraph

Article in Journal of pediatrics. Clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Thirumazhisai S GunasekaranChildren's Hospital of Los Angeles, University of Southern California, Los Angeles, CA.
Kiranmai GorlaDepartment of Pediatrics, Advocate Children's Hospital, Park Ridge, IL.
James BermanDepartment of Pediatrics, Advocate Children's Hospital, Park Ridge, IL.
Vrinda BhardwajChildren's Hospital of Los Angeles, University of Southern California, Los Angeles, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Food impaction (FI) is a manifestation of eosinophilic esophagitis (EoE) and requires endoscopic removal. We report the response to nebulized albuterol in 5 children with EoE and FI. Albuterol (2.5 mg/3 mL) was administered via nebulizer, with instructions to breathe and swallow the aerosol condensate. Four of 5 patients experienced relief of the impaction. Endoscopy with biopsies performed acutely in 1 patient and subsequently in the others confirmed EoE in all patients. This technique represents a novel approach for the nonendoscopic management of FI in EoE.

Indexed as

albuteroldysphagiaeosinophilic esophagitisfood impactionsalbutamol

Identifiers

PMID42206241
PMCPMC13208829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.